𝔖 Bobbio Scriptorium
✦   LIBER   ✦

European randomized study of screening for prostate cancer—The Rotterdam pilot studies

✍ Scribed by Fritz H. Schröder; Ronald A. M. Damhuis; Wim J. Kirkels; Harry J. De Koning; Ries Kranse; Huub G. T. Nijs; Bert G. Blijenberg

Publisher
John Wiley and Sons
Year
1996
Tongue
French
Weight
759 KB
Volume
65
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Changing role of 3 screening modalities
Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam)
✍ P.M.M. Beemsterboer; R. Kranse; H.J. de Koning; J.D.F. Habbema; F.H. Schröder 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 88 KB 👁 2 views

A randomized screening trial was started in Europe to show the effect of early detection and treatment of prostate cancer on mortality (European Study on Screening of Prostate Cancer). In one centre (Rotterdam), the screening protocol initially consisted of 3 screening tests for all men: prostate-sp

The European randomized study of screeni
The European randomized study of screening for prostate cancer : An update
✍ Bo Standaert; Louis Denis 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Background: A consensus meeting on screening and global strategy for prostate carcinoma, held in antwerp in 1994, determined the willingness among european cancer prevention centers to pursue vigorously the collaborative formation of a multinational randomized screening trial. this trial was to

Predictors for biopsy outcome in the Eur
Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam Region)
✍ Kranse, Ries; Beemsterboer, Petra; Rietbergen, John; Habbema, Dik; Hugosson, Jon 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

In the European Randomized Study of Screening for Prostate Cancer (ER-SPC, Rotterdam region), men aged 55-74 years are screened for prostate cancer by prostatespecific antigen (PSA) sampling, digital rectal examination (DRE), and transrectal ultrasound investigation (TRUS). All men with a PSA Ն4 ng/

Effective PSA contamination in the Rotte
Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer
✍ Suzie J. Otto; Ingrid W. van der Cruijsen; Michael K. Liem; Ida J. Korfage; Jan 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 93 KB 👁 2 views

## Abstract The extent of effective prostate‐specific antigen (PSA) contamination in the Rotterdam section of the ongoing European Randomized Study of Screening for Prostate Cancer (ERSPC) trial was evaluated and defined as when opportunistic PSA testing of ≥ 3.0 ng/ml was followed by biopsy, simil

Detection rates of high-grade prostate c
Detection rates of high-grade prostate cancer during subsequent screening visits. Results of the European Randomized Screening Study for Prostate Cancer
✍ Theodorus H. van der Kwast; Stefano Ciatto; Paula M. Martikainen; Robert Hoedema 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 137 KB 👁 1 views

## Abstract Screening for prostate cancer using prostate‐specific antigen (PSA) tests has led to a stage and grade shift as compared to the pre‐PSA era. Effectiveness of screening for prostate cancer should be manifested by a reduction in detection rate of aggressive cancers during subsequent scree